CN112869132A - 一种用于心脑血管疾病的保健品 - Google Patents
一种用于心脑血管疾病的保健品 Download PDFInfo
- Publication number
- CN112869132A CN112869132A CN201911209386.6A CN201911209386A CN112869132A CN 112869132 A CN112869132 A CN 112869132A CN 201911209386 A CN201911209386 A CN 201911209386A CN 112869132 A CN112869132 A CN 112869132A
- Authority
- CN
- China
- Prior art keywords
- fish
- cerebrovascular diseases
- health
- cardiovascular
- baking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 21
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 14
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 14
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 13
- 241000251468 Actinopterygii Species 0.000 claims abstract description 24
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 18
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 18
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 18
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 18
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 18
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 18
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 18
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 18
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 18
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 11
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 9
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 9
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 9
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 9
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 9
- 241000287828 Gallus gallus Species 0.000 claims abstract description 4
- 239000012528 membrane Substances 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 244000088415 Raphanus sativus Species 0.000 claims abstract 3
- 210000003038 endothelium Anatomy 0.000 claims description 6
- 235000014347 soups Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000021323 fish oil Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 229910052571 earthenware Inorganic materials 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 15
- 235000012000 cholesterol Nutrition 0.000 abstract description 13
- 210000004185 liver Anatomy 0.000 abstract description 9
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 208000007536 Thrombosis Diseases 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract description 3
- 208000029028 brain injury Diseases 0.000 abstract description 3
- 230000001815 facial effect Effects 0.000 abstract description 3
- 230000036737 immune function Effects 0.000 abstract description 3
- 230000000302 ischemic effect Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 abstract description 3
- 230000003925 brain function Effects 0.000 abstract description 2
- 230000004438 eyesight Effects 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 19
- 241001092040 Crataegus Species 0.000 description 16
- 235000015468 Lycium chinense Nutrition 0.000 description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 8
- 244000241872 Lycium chinense Species 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 241000220259 Raphanus Species 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 244000241838 Lycium barbarum Species 0.000 description 5
- 235000015459 Lycium barbarum Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000001550 testis Anatomy 0.000 description 5
- 230000034994 death Effects 0.000 description 4
- 231100000517 death Toxicity 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 206010008132 Cerebral thrombosis Diseases 0.000 description 3
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000008440 Crataegus cuneata Nutrition 0.000 description 2
- 244000160089 Crataegus cuneata Species 0.000 description 2
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000955 neuroendocrine Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000235789 Hyperoartia Species 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000038015 macular disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 108091008695 photoreceptors Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种用于心脑血管疾病的保健品,它由:七星鱼、生山楂、莱菔子、鸡内金、枸杞子为原料按一定重量配比加工配制而成。该发明经过十多年的临床实践证明,它对心脑血管疾病不仅有治疗的药用价值,而且还可起到预防的保健作用,它可平肝明目,化栓通络,降低胆固醇,促进脂肪和胆固醇的代谢,并具有减肥的功效,治疗口眼歪斜,调节免疫功能,抗衰老,抗疲劳,抗肿瘤,保护肝脏,降血压,降血糖,修复缺血性脑损伤,减轻脑水肿,改善大脑功能等作用,经临床试验,深受广大患者的衷肯和赞誉,该发明加工工艺简单,服用方便,无毒、无任何副作用,可做保健品长期服用,费用低。
Description
技术领域
本发明涉及一种用于心脑血管疾病的保健品。
背景技术
目前,在我国患有高血脂症、动脉硬化的人越来越多,因心脑血管疾病死亡者占死亡总数的45%,每年因心脑血管疾病死亡人数达260万,平均每小时死亡300人,针对这一情况大多都是采用西药来降血脂、降胆固醇,西药如他汀类药,它虽然对降血脂、降胆固醇有一定疗效,但副作用较大,长时间服用不仅医疗费用高,而且还容易引起胃肠道疾病和肌肉疼痛,因此很多人无法接受这种治疗,最终导致心脑血管疾病的发生,给患者造成极大的痛苦。
发明内容
本发明的目的在于克服上述缺点,提供一种用于心脑血管疾病的保健品,它无毒、无任何副作用,可显著的降低甘油三酯和胆固酯,对心脑血管疾病不仅有治疗的药用价值,而且还可起到预防的作用。本发明的技术方案是这样实现的,一种用于心脑血管疾病的保健品它是由下列重量的原料制成:七星鱼300—500g、生山楂20—60g、莱菔子10—30g、鸡内金10—30g、枸杞子20—50g。其制备方法是先将1—2斤的活体七星鱼整体头朝上吊挂起来,用木碳进行烘烤,烤至5—7天,将鱼油烤出,烤到每条鱼体重的50%即可,烤时注意通风,不能烤焦糊,焦糊均不可入药,再将上述重量的七星鱼、生山楂、莱菔子、鸡内金、枸杞子放入洁净的陶制品器皿中加入800—1000g水,大火煎煮2—3小时倒出汤液,再加入500—600g水,小火煎煮1—2小时再将倒出的汤液加入,再小火煎煮10—20分钟,放置温凉后装入瓶中即可服用,每天服用三次,每次服用150g即可。该发明中的七星鱼、又名七鳃鳗、八目鳗,为无脊椎动物,它产于黑龙江、乌苏里江、俄罗斯,专门吸附在大鱼上,通过吸盘吸取大鱼的油脂寄生,七鳃鳗鱼中维生素A的含量比一般鱼类含量高,每克约含99—980国际单位,平均300国际单位,在肝、心、肾、生殖腺及大肠、小肠、睾丸中含量更高,在鱼皮中维生素B1与维生素B12含莙共碱(Befaine)、肌氨基酸(Creafine)、脂肪、蛋白质、维生素A、D的含量也较其他鱼类高,腹皮中含量比背皮高,它具有平肝明目,化栓通络,滋补强壮的功效,主治夜盲症、角膜干燥、口眼歪斜、栓淤堵塞的心脑血管疾病,它不仅有药用价值,对心脑血管疾病还可起到预防作用,可有效的调节人体的酸碱平衡。山楂也叫山里红、红果、胭脂果,为蔷薇科植物山里红或山楂的干燥成熟果实,质硬,果肉薄,酸甜适中,风味独特,山楂有很高的营养价值和医疗价值,老年人常吃山楂制品能增强食欲,改善睡眠,保持骨骼和血液中钙的恒定,预防动脉粥样硬化,因此山楂被视为“长寿食品”,山楂含有大量的维生素C与微量元素,能够扩张血管,降低血压,降低血糖,能够改善和促进胆固醇排泄而降低血脂,预防高血脂的发生,山楂能够开胃促进消化,山楂所含有的脂肪酶也能够促进脂肪的消化,山楂所含有的黄酮类与维生素C、胡萝卜素等物质能够阻断并减少自由基的生成,可增强机体的免疫力,延缓衰老,防癌抗癌,山楂能够活血化瘀,帮助消除瘀血状态,辅助治疗跌打损伤,山楂对子宫有收缩作用,在孕妇临产时有催生效果,常食山楂能够扩张血管、降低血糖,降低血压,防治心血管疾病和老年性心脏病,利用山楂果实治疗疾病,在中国已有悠久的历史。《唐本草》记:汁服用止水痢,《本草纲目》记:山楂化饮食,消肉滞等,凡脾胃虚弱,食物不消化,胸腹酸刺胀闷者,于膳后Ⅱ爵两三枚绝佳,中医认为,山楂更具有生津止渴,活血化瘀等功能,而且近代药物理化研究发现山楂的药用价值渗透到血液血脂领域更为明显。枸杞子富含枸杞多糖,枸杞多糖是一种水溶性多糖,由阿拉伯糖、葡萄糖、半乳糖、甘露糖、木糖、鼠李糖这6种单糖成分组成,具有生理活性,能够增强非特异性免疫功能,提高抗病能力,抑制肿瘤生长和细胞突变,抗衰老,免疫衰老与细胞凋亡密切相关,枸杞多糖(LBP),能明显提高吞噬细胞的吞噬功能,提高淋巴细胞的增殖能力,枸杞多糖不仅是一种调节免疫反应的生物反应调节剂,而且可通过神经内分泌免疫调节发挥抗癌作用,枸杞多糖能显著增加小鼠肌糖原、肝糖原储备量,提高运动前后血液乳酸脱氢酶总活力,降低小鼠剧烈运动后血尿素氮增加量,加快运动后血尿素氮的清除速率,这表明枸杞多糖对消除疲劳具有十分明显的作用,抗辐射损伤,枸杞子有抗Y射线辐射、保护机体的作用,可作为辅助药物来配合放疗等抗肿瘤治疗,减轻放疗的毒副作用,提高疗效,保护机体的免疫功能,调节血脂,枸杞子能有效降低患高脂血症的大鼠血清中甘油三酯和胆固醇的含量,具有明显的降血脂、调节脂类代谢功能,对预防心血管疾病具有积极作用,降血糖,枸杞多糖能明显增强受损胰岛细胞内超氧化物歧化酶(SOD)的活性,提高胰岛细胞的抗氧化能力,减轻过氧化物对细胞的损伤,降低内二醛生成量,这表明枸杞多糖对胰岛细胞有一定的保护作用,降血压,枸杞多糖可降低大鼠血压(收缩压和舒张压均见效果),降低血浆及血管中丙二醛、内皮素含量,增加降钙素基因相关肽的释放,防止高血压形成,保护生殖系统,枸杞多糖可使睾丸受损伤的大鼠的血清性激素水平升高,增加睾丸、附睾的脏器系数,提高大鼠睾丸组织SOD活性,降低丙二醛含量,使受损的睾丸组织恢复到接近正常水平,提高视力,人体的视网膜光感受器是由视黄醇和视蛋白所构成,枸杞中所含丰富的B-胡萝卜素可在人体内转化成维生素A,而维生素A可生成视黄醇,从而提高视力,防止黄斑症,提高呼吸道抗病能力,枸杞富含胡萝卜素,在人体内能转化成维生素A,具有维持上皮组织正常生长与分化的功能,量充足时可预防鼻、咽、喉和其他呼吸道感染,提高呼吸道抗病能力,美容养颜,滋润肌肤,皮肤衰老主要是由于自由基氧化所造成,而枸杞中所含的枸杞多糖、B-胡萝卜素都是强力的抗氧化剂,再加上枸杞所含的微量元素硒和维生素E的协同作用,组成了强大的抗氧化部队,另外,维生素A可维持上皮组织的生长与分化,防止皮肤干燥和毛囊角化,从而起到美容养颜、滋润肌肤的作用,保护肝脏,抗脂肪肝,枸杞中所含的甜菜碱有抑制脂肪在肝细胞内沉积、促进肝细胞新生的作用,同时可防止四氯化碳引起的肝功能紊乱,故而枸杞具有明确的保护肝脏、抗脂肪肝的功效,增强造血功能,枸杞所含枸杞多糖可保护白细胞,促进机体造血功能恢复,此外,宁夏枸杞还具有调节神经内分泌、修复缺血性脑损伤、减轻脑水肿、改善大脑功能等作用。鸡内金,在《滇南本草》中记载,它具有宽中健脾、消食磨胃、治小儿乳食结滞、肚大筋青,痞积疳积,可治眼目障翳。莱菔子《本草纲目》记载,莱菔子之功,长于利气,生能升,熟能降,升则吐风痰,散风寒,发疮疹,降则定痰喘咳嗽,调下痢后重,止内痛,皆是利气之功效,其味辛过于根,以其辛甚,故升降之功亦烈于根也。
该发明经过十多年的临床实践证明,它对心脑血管疾病不仅有治疗的药用价值,而且还可起到预防的保健作用,它可平肝明目,化栓通络,降低胆固醇,促进脂肪和胆固醇的代谢,并具有减肥的功效,治疗口眼歪斜,调节免疫功能,抗衰老,抗疲劳,抗肿瘤,保护肝脏,降血压,降血糖,修复缺血性脑损伤,减轻脑水肿,改善大脑功能等作用,经临床试验,深受广大患者的衷肯和赞誉,该发明加工工艺简单,服用方便,无毒、无任何副作用,可做保健品长期服用,费用低,便于广泛推广使用。
该发明十多年来,经过服用的患者近百名,下边仅举5例典型的病例。
病例1,刘××,男,67岁,患有脑血栓,口歪眼斜,走路不稳,说话口齿不清,医院大生化,血清总胆固醇(CHOL)8.26、甘油三酯(TG)4.27,高密度胆固醇(HDL)1.92,低密度胆固醇(LDL)4.12,服用该保健品,每天服三次,每次服用150g,服用半个月后,说话比以前清楚了,连续服用一个月,口歪眼斜和走路不稳有明显改善,该患者连续服用2个月,去医院化验血清总胆固醇(CHOL)4.10、甘油三酯(TG)1.70,高密度胆固醇(HDL)1.95,低密度胆固醇(LDL)3.12,各项指标均已达到正常值,该患者基本恢复正常人标准。
病例2,张××,男,72岁,因脑血栓住院治疗,出院后左半身不遂,左手和腿走路不听使唤,通过服用该保健品,每天服三次,每次服用150g,服20天后,感觉腿脚比之前有劲了,血压从原来的100-180mmHg,降到90-150mmHg,血糖空腹比之前稳定了,基本达到7.0左右,连续服用五十天,手能握住东西了,腿脚走路也有明显改善。
病例3,刘××,女,73岁,患有高血压、高血糖、高血脂,2015年突然感到手脚麻木,说话口齿不清,去医院检查,血清总胆固醇、甘油三酯、高密度胆固醇、低密度胆固醇各项指标都不正常,属于脑血栓前兆,住院治疗一段时间后有所改善,但出院后通过服用该保健品每天服用三次,每次服用150g,连续服用2个月,去医院化验各项指标均达到正常水平,口齿说话比之前清楚了,手脚麻木也有了很大的改善。
病例4,赵××,男,69岁,患有脑血栓后遗症多年,偏瘫在床,服用该保健品2个月,能够自己翻身了,连续服用3个月能自己坐起来,而且病人的痛苦减轻了很多。
病例5,高××,男,56岁,长期酗酒,体重190斤,高血压、高血脂、高血糖,服用该保健品3个月,体重降至158斤,高血压、高血脂基本恢复正常指标,高血糖基本稳定,控制在6.0-7.0之间。
具体实施方法:
实施例1,最佳实施例,取七星鱼500g、生山楂60g、莱菔子30g、鸡内金30g、枸杞子50g。
实施例2,取七星鱼400g、生山楂30g、莱菔子20g、鸡内金20g、枸杞子30g。
实施例3,取七星鱼300g、生山楂20g、莱菔子10g、鸡内金10g、枸杞子20g。
以上三个实施例的制备方法是:先将1-2斤的活体七星鱼整体头朝上吊挂起来,用木碳进行烘烤,烤至5-7天,将鱼油烤出,烤到每条鱼体重的50%即可,烤时注意通风,不能烤焦糊,焦糊均不可入药,再将上述重量的七星鱼、生山楂、莱菔子、鸡内金、枸杞子放入洁净的陶制品器皿中加入800-1000g水,大火煎煮2-3小时,倒出汤液再加入500-600g水,小火煎煮1-2小时,将倒出的汤液加入,再小火煎煮10-20分钟,放置温凉后装入瓶中即可。
每天服用三次,每次服用150g,可长期服用。
该发明已经过黑龙江中医药大学中医药研究所对大鼠进行了模拟实验,均证明通过大鼠服用后,可降低胆固醇、降低高血脂、降低甘油三酯,促进胆固醇的代谢。
Claims (2)
1.一种用于心脑血管疾病的保健品,其特征在于:它是由下列重量的原料制成:七星鱼300—500g、生山楂20—60g、莱菔子10—30g、鸡内金10—30g、枸杞子20—50g。
2.根据权利要求1所述的一种用于心脑血管疾病的保健品的制备方法,其特征在于:
a.先将1—2斤的活体七星鱼整体头朝上吊挂起来,用木碳进行烘烤,烤至5—7天,将鱼油烤出,烤到每条鱼体重的50%即可,烤时注意通风,不能烤焦糊,焦糊均不可入药;
b.再将上述重量的七星鱼、生山楂、莱菔子、鸡内金、枸杞子放入洁净的陶制品器皿中加入800—1000g水,大火煎煮2—3小时倒出汤液,再加入500—600g水,小火煎煮1—2小时再将倒出的汤液加入,再小火煎煮10—20分钟,放置温凉后装入瓶中即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911209386.6A CN112869132A (zh) | 2019-12-01 | 2019-12-01 | 一种用于心脑血管疾病的保健品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911209386.6A CN112869132A (zh) | 2019-12-01 | 2019-12-01 | 一种用于心脑血管疾病的保健品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112869132A true CN112869132A (zh) | 2021-06-01 |
Family
ID=76039390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911209386.6A Pending CN112869132A (zh) | 2019-12-01 | 2019-12-01 | 一种用于心脑血管疾病的保健品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112869132A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1509749A (zh) * | 2002-12-25 | 2004-07-07 | 叶高瑞 | 一种番木瓜蛋白酶水解七星鱼蛋白核酸制剂及其制作方法 |
WO2013117732A1 (en) * | 2012-02-10 | 2013-08-15 | Nestec S.A. | Hawthorn and phytosterols and their effect on cardiovascular diseases |
CN106344769A (zh) * | 2016-12-04 | 2017-01-25 | 黄龙 | 一种治疗夜盲症的中药汤剂 |
-
2019
- 2019-12-01 CN CN201911209386.6A patent/CN112869132A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1509749A (zh) * | 2002-12-25 | 2004-07-07 | 叶高瑞 | 一种番木瓜蛋白酶水解七星鱼蛋白核酸制剂及其制作方法 |
WO2013117732A1 (en) * | 2012-02-10 | 2013-08-15 | Nestec S.A. | Hawthorn and phytosterols and their effect on cardiovascular diseases |
CN106344769A (zh) * | 2016-12-04 | 2017-01-25 | 黄龙 | 一种治疗夜盲症的中药汤剂 |
Non-Patent Citations (5)
Title |
---|
《中国药用动物志》协作组编著: "《中国药用动物志》", 31 August 1979, 天津科学技术出版社 * |
伍汉霖主编: "《有毒、药用及危险鱼类图鉴》", 30 June 2005, 上海科学技术出版社 * |
张尔贤等: "海洋生物活性物质开发利用的现状与前景", 《台湾海峡》 * |
张金鼎主编: "《海洋药物与效方》", 31 August 1998, 中医古籍出版社 * |
李庆伟等: "雷氏七鳃鳗(Lampetra reissneri)消化系统组成及消化液主要组分的鉴定分析", 《辽宁师范大学学报(自然科学版)》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101703134A (zh) | 一种保健茶 | |
CN107397208B (zh) | 以鱼鳔胶为主成分的功能食品及其用途 | |
CN103859379A (zh) | 一种有助于改善记忆的养生保健食品配方及其制备方法 | |
CN106136048A (zh) | 中老年用健康粥粉及其制备方法 | |
Yampolsky et al. | Apricot (lat. Prunus armeniaca Lin.) | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
CN110973527A (zh) | 一种健康减肥剂 | |
CN108186966A (zh) | 一种预防或改善老年痴呆症的组合物及其应用 | |
CN112869132A (zh) | 一种用于心脑血管疾病的保健品 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN110935002A (zh) | 具有降血压功效的组合物及其应用 | |
CN109289017A (zh) | 用于清理血管和血液的组合物及制备方法 | |
CN1660207A (zh) | 降低血脂和胆固醇的保健制剂及其生产方法 | |
CN115414448B (zh) | 一种具有神经保护作用的中药组合物、制备方法及应用 | |
CN108883145A (zh) | 一种内服外涂结合治疗爱滋病、肿瘤的药剂 | |
CN105561192A (zh) | 虫草沙棘保健药酒 | |
CN114847482A (zh) | 一种防治风湿药膳产品及其加工方法 | |
KR100882784B1 (ko) | 관절염 치료 효과를 지니는 기능성 식품 조성물 | |
CN114668058A (zh) | 一种降脂减肥保健茶及其制备方法 | |
CN112617199A (zh) | 一种兼备美容养颜的减肥瘦身制剂 | |
CN118078927A (zh) | 用于健脾养胃的药物组合物、餐粉及其制备方法和应用 | |
CN114869981A (zh) | 一种山楂八物膏及其制备方法 | |
CN112244290A (zh) | 一种活血化瘀药膳及其制备方法 | |
CN115006461A (zh) | 用于治疗痛风的中药组合物及其制备方法、用途 | |
CN104509787A (zh) | 一种预防妊娠期糖尿病的养生粥及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210601 |